Galena Biopharma Inc. (GALE) announced Wednesday morning that the Independent Data Monitoring Committee for its Phase 3 trial of NeuVax has recommended that the study by stopped due to futility.
from RTT - Before the Bell http://ift.tt/296F7in
via IFTTT
No comments:
Post a Comment